Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients Publisher Pubmed



Ghanbari R1 ; Teimoori A2 ; Sadeghi A1 ; Mohamadkhani A1 ; Rezasoltani S3 ; Asadi E4 ; Jouyban A5 ; Sumner SCJ6
Authors

Source: Future Microbiology Published:2020


Abstract

COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing broad-spectrum antiviral drugs could be an effective strategy to respond immediately. In this review, a number of broad-spectrum antivirals with potential efficacy to inhibit the virus replication via targeting the virus spike protein (S protein), RNA-dependent RNA polymerase (RdRp), 3-chymotrypsin-like protease (3CLpro) and papain-like protease (PLpro) that are critical in the pathogenesis and life cycle of coronavirus, have been evaluated as possible treatment options against SARS-CoV-2 in COVID-19 patients. © 2021 Future Medicine Ltd
Other Related Docs
4. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
15. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
19. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)